Journey Medical Corp 8-K

What Happened
Journey Medical Corporation (DERM) issued a press release on March 25, 2026 to provide a corporate update and to announce its financial results for the full year ended December 31, 2025. That press release is furnished as Exhibit 99.1 to the Form 8-K. The company notes the information in the Form 8-K (including Exhibit 99.1) is being furnished — not filed — and therefore is not subject to the liability provisions of Section 18 of the Exchange Act or automatically incorporated by reference into other Securities Act filings. A cover page iXBRL interactive data file (Exhibit 104) was also furnished.

Key Details

• Press release date: March 25, 2026.
• Reporting period: full year ended December 31, 2025.
• Exhibit furnished: 99.1 (press release) and 104 (iXBRL cover page).
• Disclosure status: information furnished, not filed; not subject to Section 18 liability and not automatically incorporated by reference.

Why It Matters
This filing signals that Journey Medical has released its annual earnings and revenue details for 2025; investors should read the furnished press release (Exhibit 99.1) for the specific financial figures (revenue, earnings/loss, margins, and any guidance or corporate updates). Because the material is furnished rather than filed, investors should also look for the company’s subsequent SEC filings (such as the Form 10-K) for audited financial statements and formal disclosures that carry different legal and reporting implications.